Prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous tumors with early and limited disease after completely removed

Chong Wang,Yun Jia,Guanjun Shi,Lubiao An,Xiwen Fan,Pu Zhang,Ruiqing Ma
DOI: https://doi.org/10.1097/md.0000000000040599
IF: 1.6
2024-11-28
Medicine
Abstract:Mucous tumors of the appendix are a rare malignancy that are the main cause of pseudomyxoma peritonei (PMP), a clinical syndrome that causes mucinous ascites and mucinous tumor implantation along the abdominal and pelvic cavity. [ 1 , 2 ] The mucinous epithelial neoplasms of the appendix included: serrated polyp, low-grade mucinous neoplasm (LAMN), high-grade mucinous neoplasm (HAMN), and mucinous adenocarcinoma (with or without signet ring cells). The prognosis of LAMN was significantly better than that of HAMN and mucinous adenocarcinoma. PMP mainly originated from LAMN and had separate histological subtypes (sometimes with discordance), including disseminated peritoneal adenomucinosis (DPAM); peritoneal mucinous carcinomatosis (PMCA), and PMCA with signet ring cells. [ 3 ] Primary LAMN can be detected unexpectedly in any abdominal surgery, especially acute appendicitis. Patients with PMP can achieve a pretty good prognosis after undergoing complete or near complete cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC), [ 4 , 5 ] a standard treatment for tumors with peritoneal metastases. The possibility of recurrence or progression to PMP may occur after being completely removed for a long time. This may be related to the pathological characteristics of the appendix, including appendiceal perforation, positive surgical margin, and mucus distribution. For these patients, the necessity of prophylactic cytoreductive surgery (PCRS) and HIPEC is confusing.
medicine, general & internal
What problem does this paper attempt to address?